Annual Operating Profit:
$23.02M+$13.20M(+134.41%)Summary
- As of today, LGND annual operating income is $23.02 million, with the most recent change of +$13.20 million (+134.41%) on December 31, 2024.
- During the last 3 years, LGND annual operating profit has fallen by -$43.23 million (-65.25%).
- LGND annual operating profit is now -85.94% below its all-time high of $163.73 million, reached on December 31, 2018.
Performance
LGND Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$9.72M+$46.38M(+126.51%)Summary
- As of today, LGND quarterly operating income is $9.72 million, with the most recent change of +$46.38 million (+126.51%) on June 30, 2025.
- Over the past year, LGND quarterly operating profit has increased by +$2.33 million (+31.51%).
- LGND quarterly operating profit is now -86.15% below its all-time high of $70.17 million, reached on June 30, 2018.
Performance
LGND Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$14.30M+$2.33M(+14.01%)Summary
- As of today, LGND TTM operating income is -$14.30 million, with the most recent change of +$2.33 million (+14.01%) on June 30, 2025.
- Over the past year, LGND TTM operating profit has dropped by -$22.27 million (-279.21%).
- LGND TTM operating profit is now -108.73% below its all-time high of $163.73 million, reached on December 31, 2018.
Performance
LGND TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
LGND Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +134.4% | +31.5% | -279.2% |
| 3Y3 Years | -65.3% | +12.2% | -122.3% |
| 5Y5 Years | +502.4% | +36.9% | -420.9% |
LGND Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -65.3% | +134.4% | -31.6% | +126.5% | -123.5% | +14.0% |
| 5Y | 5-Year | -65.3% | +502.4% | -78.8% | +126.5% | -113.8% | +14.0% |
| All-Time | All-Time | -85.9% | +133.1% | -86.2% | +122.0% | -108.7% | +85.4% |
LGND Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $9.72M(+126.5%) | -$14.30M(+14.0%) |
| Mar 2025 | - | -$36.66M(-2273.0%) | -$16.63M(-172.2%) |
| Dec 2024 | $23.02M(+134.4%) | $1.69M(-84.6%) | $23.02M(+28.1%) |
| Sep 2024 | - | $10.96M(+48.2%) | $17.98M(+125.3%) |
| Jun 2024 | - | $7.39M(+147.4%) | $7.98M(+671.5%) |
| Mar 2024 | - | $2.99M(+189.0%) | -$1.40M(-114.2%) |
| Dec 2023 | $9.82M(-23.5%) | -$3.36M(-450.9%) | $9.82M(+241.9%) |
| Sep 2023 | - | $957.00K(+148.3%) | -$6.92M(-255.0%) |
| Jun 2023 | - | -$1.98M(-114.0%) | $4.46M(-70.5%) |
| Mar 2023 | - | $14.21M(+170.7%) | $15.11M(+397.5%) |
| Dec 2022 | $12.84M(-80.6%) | -$20.10M(-262.9%) | $3.04M(-95.0%) |
| Sep 2022 | - | $12.34M(+42.5%) | $60.83M(-5.2%) |
| Jun 2022 | - | $8.66M(+306.1%) | $64.19M(-36.6%) |
| Mar 2022 | - | $2.13M(-94.3%) | $101.27M(-2.5%) |
| Dec 2021 | $66.25M(+658.8%) | $37.69M(+140.0%) | $103.85M(+44.4%) |
| Sep 2021 | - | $15.71M(-65.7%) | $71.91M(+19.9%) |
| Jun 2021 | - | $45.74M(+870.1%) | $59.95M(+181.3%) |
| Mar 2021 | - | $4.71M(-18.0%) | $21.31M(+4.5%) |
| Dec 2020 | $8.73M(+252.6%) | $5.75M(+53.5%) | $20.39M(+357.5%) |
| Sep 2020 | - | $3.75M(-47.2%) | $4.46M(+200.2%) |
| Jun 2020 | - | $7.10M(+87.4%) | -$4.45M(+71.6%) |
| Mar 2020 | - | $3.79M(+137.2%) | -$15.68M(-174.1%) |
| Dec 2019 | -$5.72M(-103.5%) | -$10.18M(-97.3%) | -$5.72M(-115.2%) |
| Sep 2019 | - | -$5.16M(-24.9%) | $37.61M(-43.1%) |
| Jun 2019 | - | -$4.13M(-130.0%) | $66.13M(-52.9%) |
| Mar 2019 | - | $13.75M(-58.5%) | $140.43M(-14.2%) |
| Dec 2018 | $163.73M(+140.5%) | $33.15M(+41.9%) | $163.73M(+3.0%) |
| Sep 2018 | - | $23.36M(-66.7%) | $158.93M(+4.5%) |
| Jun 2018 | - | $70.17M(+89.5%) | $152.06M(+60.2%) |
| Mar 2018 | - | $37.04M(+30.7%) | $94.90M(+39.4%) |
| Dec 2017 | $68.08M(+51.6%) | $28.35M(+71.9%) | $68.07M(+15.2%) |
| Sep 2017 | - | $16.49M(+26.7%) | $59.08M(+22.9%) |
| Jun 2017 | - | $13.02M(+27.4%) | $48.05M(+23.2%) |
| Mar 2017 | - | $10.22M(-47.2%) | $39.01M(-11.1%) |
| Dec 2016 | $44.92M(+58.4%) | $19.36M(+254.1%) | $43.89M(+26.3%) |
| Sep 2016 | - | $5.47M(+37.7%) | $34.76M(-9.1%) |
| Jun 2016 | - | $3.97M(-73.7%) | $38.24M(-1.6%) |
| Mar 2016 | - | $15.10M(+47.6%) | $38.85M(+42.2%) |
| Dec 2015 | $28.35M(+36.9%) | $10.23M(+14.4%) | $27.33M(+0.1%) |
| Sep 2015 | - | $8.94M(+95.1%) | $27.30M(+23.7%) |
| Jun 2015 | - | $4.58M(+28.3%) | $22.07M(+16.3%) |
| Mar 2015 | - | $3.57M(-65.0%) | $18.98M(-8.4%) |
| Dec 2014 | $20.71M(+29.6%) | $10.20M(+174.6%) | $20.71M(+20.8%) |
| Sep 2014 | - | $3.71M(+148.6%) | $17.14M(+2.5%) |
| Jun 2014 | - | $1.49M(-71.8%) | $16.72M(-3.2%) |
| Mar 2014 | - | $5.30M(-20.0%) | $17.27M(+8.0%) |
| Dec 2013 | $15.98M(+1697.9%) | $6.63M(+101.0%) | $15.98M(+14.3%) |
| Sep 2013 | - | $3.30M(+61.8%) | $13.98M(+48.4%) |
| Jun 2013 | - | $2.04M(-49.3%) | $9.43M(+57.4%) |
| Mar 2013 | - | $4.02M(-13.1%) | $5.99M(+392.8%) |
| Dec 2012 | $889.00K(+735.0%) | $4.63M(+467.1%) | $1.22M(-21.3%) |
| Sep 2012 | - | -$1.26M(+10.0%) | $1.54M(+9.5%) |
| Jun 2012 | - | -$1.40M(-86.3%) | $1.41M(-9.6%) |
| Mar 2012 | - | -$752.00K(-115.2%) | $1.56M(+521.1%) |
| Dec 2011 | -$140.00K(+98.8%) | $4.96M(+455.4%) | $251.00K(-97.1%) |
| Sep 2011 | - | -$1.40M(-11.4%) | $8.55M(+239.0%) |
| Jun 2011 | - | -$1.25M(+39.2%) | -$6.15M(+31.3%) |
| Mar 2011 | - | -$2.06M(-115.5%) | -$8.95M(+21.1%) |
| Dec 2010 | -$11.36M(+29.6%) | $13.26M(+182.4%) | -$11.35M(+74.9%) |
| Sep 2010 | - | -$16.10M(-297.2%) | -$45.20M(-59.6%) |
| Jun 2010 | - | -$4.05M(+8.9%) | -$28.33M(+0.6%) |
| Mar 2010 | - | -$4.45M(+78.4%) | -$28.49M(+10.5%) |
| Dec 2009 | -$16.14M | -$20.60M(-2761.0%) | -$31.85M(-118.1%) |
| Sep 2009 | - | $774.00K(+118.4%) | -$14.60M(+32.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$4.22M(+46.0%) | -$21.73M(+6.1%) |
| Mar 2009 | - | -$7.81M(-132.9%) | -$23.15M(+16.5%) |
| Dec 2008 | -$27.04M(+50.8%) | -$3.35M(+47.2%) | -$27.73M(+19.3%) |
| Sep 2008 | - | -$6.36M(-12.8%) | -$34.38M(+6.4%) |
| Jun 2008 | - | -$5.63M(+54.5%) | -$36.75M(+19.2%) |
| Mar 2008 | - | -$12.39M(-23.8%) | -$45.49M(+26.8%) |
| Dec 2007 | -$54.94M(-50.1%) | -$10.01M(-14.7%) | -$62.14M(+17.6%) |
| Sep 2007 | - | -$8.72M(+39.3%) | -$75.39M(+15.4%) |
| Jun 2007 | - | -$14.37M(+50.5%) | -$89.12M(+4.0%) |
| Mar 2007 | - | -$29.04M(-24.9%) | -$92.81M(-18.9%) |
| Dec 2006 | -$36.61M(-38.3%) | -$23.26M(-3.6%) | -$78.08M(+0.4%) |
| Sep 2006 | - | -$22.45M(-24.3%) | -$78.38M(-29.5%) |
| Jun 2006 | - | -$18.06M(-26.2%) | -$60.52M(-23.6%) |
| Mar 2006 | - | -$14.31M(+39.2%) | -$48.97M(+2.9%) |
| Dec 2005 | -$26.47M(+29.2%) | -$23.56M(-413.4%) | -$50.42M(-535.9%) |
| Sep 2005 | - | -$4.59M(+29.5%) | $11.57M(+1995.8%) |
| Jun 2005 | - | -$6.51M(+58.7%) | $552.00K(+104.6%) |
| Mar 2005 | - | -$15.77M(-141.0%) | -$12.07M(+21.5%) |
| Dec 2004 | -$37.37M(-94.9%) | $38.44M(+346.3%) | -$15.38M(+84.3%) |
| Sep 2004 | - | -$15.61M(+18.4%) | -$98.00M(-8.2%) |
| Jun 2004 | - | -$19.13M(-0.2%) | -$90.59M(-12.5%) |
| Mar 2004 | - | -$19.08M(+56.8%) | -$80.54M(-8.8%) |
| Dec 2003 | -$19.18M(+20.6%) | -$44.19M(-439.3%) | -$74.02M(-34.4%) |
| Sep 2003 | - | -$8.19M(+9.7%) | -$55.07M(-2.6%) |
| Jun 2003 | - | -$9.07M(+27.8%) | -$53.66M(+0.7%) |
| Mar 2003 | - | -$12.56M(+50.2%) | -$54.07M(-23.3%) |
| Dec 2002 | -$24.15M(-4.4%) | -$25.25M(-272.0%) | -$43.85M(-107.3%) |
| Sep 2002 | - | -$6.79M(+28.4%) | -$21.16M(-11.8%) |
| Jun 2002 | - | -$9.47M(-303.7%) | -$18.93M(-10.6%) |
| Mar 2002 | - | -$2.35M(+7.9%) | -$17.12M(+26.0%) |
| Dec 2001 | -$23.14M(+49.6%) | -$2.55M(+44.1%) | -$23.14M(+22.9%) |
| Sep 2001 | - | -$4.56M(+40.5%) | -$30.00M(+16.4%) |
| Jun 2001 | - | -$7.67M(+8.4%) | -$35.88M(+14.1%) |
| Mar 2001 | - | -$8.37M(+11.1%) | -$41.79M(+7.1%) |
| Dec 2000 | -$45.88M(+18.5%) | -$9.41M(+9.8%) | -$44.98M(+13.9%) |
| Sep 2000 | - | -$10.44M(+23.1%) | -$52.23M(+8.3%) |
| Jun 2000 | - | -$13.58M(-17.5%) | -$56.93M(+5.4%) |
| Mar 2000 | - | -$11.55M(+30.6%) | -$60.15M(+1.9%) |
| Dec 1999 | -$56.29M(+19.2%) | -$16.66M(-10.1%) | -$61.30M(+10.6%) |
| Sep 1999 | - | -$15.13M(+9.9%) | -$68.53M(+2.5%) |
| Jun 1999 | - | -$16.80M(-32.3%) | -$70.30M(-0.9%) |
| Mar 1999 | - | -$12.70M(+46.9%) | -$69.70M(-0.1%) |
| Dec 1998 | -$69.63M(-125.8%) | -$23.90M(-41.4%) | -$69.60M(-46.2%) |
| Sep 1998 | - | -$16.90M(-4.3%) | -$47.60M(-16.1%) |
| Jun 1998 | - | -$16.20M(-28.6%) | -$41.00M(-19.9%) |
| Mar 1998 | - | -$12.60M(-563.2%) | -$34.20M(-11.4%) |
| Dec 1997 | -$30.84M(+6.2%) | -$1.90M(+81.6%) | -$30.70M(+22.1%) |
| Sep 1997 | - | -$10.30M(-9.6%) | -$39.40M(-9.1%) |
| Jun 1997 | - | -$9.40M(-3.3%) | -$36.10M(-1.4%) |
| Mar 1997 | - | -$9.10M(+14.2%) | -$35.60M(-9.2%) |
| Dec 1996 | -$32.86M(-29.9%) | -$10.60M(-51.4%) | -$32.60M(-10.9%) |
| Sep 1996 | - | -$7.00M(+21.3%) | -$29.40M(+2.3%) |
| Jun 1996 | - | -$8.90M(-45.9%) | -$30.10M(-90.5%) |
| Mar 1996 | - | -$6.10M(+17.6%) | -$15.80M(-14.5%) |
| Dec 1995 | -$25.30M(-21.3%) | -$7.40M(+3.9%) | -$13.80M(-23.2%) |
| Sep 1995 | - | -$7.70M(-242.6%) | -$11.20M(-34.9%) |
| Jun 1995 | - | $5.40M(+231.7%) | -$8.30M(+57.2%) |
| Mar 1995 | - | -$4.10M(+14.6%) | -$19.40M(+7.2%) |
| Dec 1994 | -$20.85M(-46.5%) | -$4.80M(0.0%) | -$20.90M(-29.8%) |
| Sep 1994 | - | -$4.80M(+15.8%) | -$16.10M(-42.5%) |
| Jun 1994 | - | -$5.70M(-1.8%) | -$11.30M(-101.8%) |
| Mar 1994 | - | -$5.60M | -$5.60M |
| Dec 1993 | -$14.23M(-14.0%) | - | - |
| Dec 1992 | -$12.48M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual operating income?
- What is the all-time high annual operating profit for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual operating profit year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly operating income?
- What is the all-time high quarterly operating profit for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM operating income?
- What is the all-time high TTM operating profit for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM operating profit year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual operating income?
The current annual operating profit of LGND is $23.02M
What is the all-time high annual operating profit for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual operating income is $163.73M
What is Ligand Pharmaceuticals Incorporated annual operating profit year-on-year change?
Over the past year, LGND annual operating income has changed by +$13.20M (+134.41%)
What is Ligand Pharmaceuticals Incorporated quarterly operating income?
The current quarterly operating profit of LGND is $9.72M
What is the all-time high quarterly operating profit for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly operating income is $70.17M
What is Ligand Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
Over the past year, LGND quarterly operating income has changed by +$2.33M (+31.51%)
What is Ligand Pharmaceuticals Incorporated TTM operating income?
The current TTM operating profit of LGND is -$14.30M
What is the all-time high TTM operating profit for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM operating income is $163.73M
What is Ligand Pharmaceuticals Incorporated TTM operating profit year-on-year change?
Over the past year, LGND TTM operating income has changed by -$22.27M (-279.21%)